GAL and rheumatoid arthritis: Absence of terminal Gal residues is associated with inflammation, and the addition of a sialic acid to the terminal Gal residues produces an anti-inflammatory molecule that appears to be the active component in intravenous IgG treatments for severe cases of rheumatoid arthritis (36).